Revenue ($USD) : $1,150,981,000
R&D spend : $75,510,000.00
Employees : 6,846
Fiscal year end : 12/31/22
CEO : Fred Lampropoulos
Merit Medical spent $100 million on Angiodynamics dialysis portfolio products, including DuraFlow, DuraMax, Evenmore, Schon XL, Trio-CT and Vaxel Plus hemodialysis catheter brands. The deal with Angiodynamics also included the BioSentry tract sealant system biopsy brand.
In addition, Merit spent $32.5 million on the Surfacer inside-out access catheter system from BlueGrass Vascular Technologies. –CN